A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Published:
April 23, 2024
by Sanofi SA
|
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "SYNTHESIS OF 6-FLUORO-2-METHYLBENZO[D]THIAZOL-5-YL COMPOUNDS"
Published:
April 23, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION FILES APPLICATION FOR "SYSTEM FOR DETERMINING TRUE NEURAL ACTIVATION CHANGES"
Published:
April 23, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: THE GENERAL HOSPITAL CORPORATION, MASSACHUSETTS EYE AND EAR INFIRMARY, BANNER HEALTH FILES APPLICATION FOR "COMPOSITIONS AND METHODS USING REELIN IN ALZHEIMER'S DISEASE"
Published:
April 23, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: THE BROAD INSTITUTE, INC., BIOGEN MA INC. FILES APPLICATION FOR "GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF"
Published:
April 23, 2024
by U.S. Fed News
|
Ask us about our Tissue & Hygiene market view